Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy-Related Toxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00025298
What this trial is testing

Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerOral Complications+1 more
European Organisation for Research and Treatment of Cancer - EORTC 5
Not applicableStudy completedNCT05403736
What this trial is testing

Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial

Who this might be right for
Cancer
Cedars-Sinai Medical Center 20
Not applicableStudy completedNCT01719562
What this trial is testing

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Who this might be right for
Cardiac ToxicityMalignant NeoplasmBreast Cancer
Wake Forest University Health Sciences 28
Not applicableNot Yet RecruitingNCT07408362
What this trial is testing

Early Diagnosis and Cardiovascular Risk Stratification in Children Exposed to Cancer Therapies

Who this might be right for
Cancer Therapy-related Cardiovascular ToxicityChildhood CancerChemotherapeutic Toxicity+2 more
Centre Hospitalier Universitaire de Liege 100
Not applicableLooking for participantsNCT01993498
What this trial is testing

Chronic Toxicities Related to Treatment in Patients With Localized Cancer

Who this might be right for
Breast Cancer Nos Metastatic RecurrentEarly Lung Cancer
UNICANCER 14,750
Not applicableEnded earlyNCT05781672
What this trial is testing

Prediction of Delayed Toxic Cardiomyopathy in Children

Who this might be right for
CardiotoxicityChildhood Cancer
University Hospital, Montpellier 134
Not applicableStudy completedNCT02794636
What this trial is testing

Interferon Toxicities in Melanoma Treatment

Who this might be right for
Stage III Melanoma
Bristol-Myers Squibb 436
Post-approval studies (Phase 4)Study completedNCT04070469
What this trial is testing

Plasma Concentrations of Amoxicillin Administered in High-doses During the First Week of Treatment (MAX-AMOX)

Who this might be right for
Infection, Bacterial
University Hospital, Clermont-Ferrand 142
Not applicableLooking for participantsNCT07484932
What this trial is testing

TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer

Who this might be right for
Cancer (Solid Tumors)Geriatric Oncology
The University of Hong Kong 400
Not applicableUnknownNCT02942615
What this trial is testing

The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.

Who this might be right for
Breast NeoplasmsCardiotoxicity
Ruijin Hospital 220
Not applicableWithdrawnNCT01621048
What this trial is testing

Evaluation of Treatment Related Toxicity After Radiotherapy for Head and Neck Cancer

Who this might be right for
Head and Neck NeoplasmsXerostomiaDeglutition Disorders
Universitaire Ziekenhuizen KU Leuven
Large-scale testing (Phase 3)UnknownNCT04651439
What this trial is testing

Severe Bullous Drug Eruption and Filgrastim

Who this might be right for
Rare DiseasesToxic Epidermal Necrolyses
Hospices Civils de Lyon 42
Testing effectiveness (Phase 2)WithdrawnNCT00003407
What this trial is testing

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaMyelodysplastic Syndromes+1 more
Rush University Medical Center
Post-approval studies (Phase 4)UnknownNCT05730777
What this trial is testing

Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics

Who this might be right for
Cancer Therapy-related Cardiovascular Toxicity
Peking University Third Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT05022797
What this trial is testing

Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS

Who this might be right for
Diffuse Large B-Cell LymphomaDrug Toxicity
Fundacion CRIS de Investigación para Vencer el Cáncer 3
Testing effectiveness (Phase 2)WithdrawnNCT00372723
What this trial is testing

Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)

Who this might be right for
Toxic Epidermal Necrolysis
Loyola University
Early research (Phase 1)Study completedNCT00003268
What this trial is testing

Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemia
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Not applicableUnknownNCT06048458
What this trial is testing

Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping

Who this might be right for
Cardiovascular DiseasesCardiotoxicityFluorouracil Adverse Reaction+5 more
University College, London 75
Post-approval studies (Phase 4)Study completedNCT00202228
What this trial is testing

Lactate Metabolism Study in HIV Infected Persons

Who this might be right for
HIV InfectionsAIDSLactic Acidosis+1 more
Queen's University 30
Testing effectiveness (Phase 2)WithdrawnNCT02319616
What this trial is testing

Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis

Who this might be right for
Toxic Epidermal Necrolysis
University of California, Davis
Next Page